Heme oxygenase-1 (HO-1) is a ubiquitous 32-kDa protein expressed in many tissues and highly inducible. They catalyze the degradation of the heme group and the release of free iron, carbon monoxide, and biliverdin; the latter converted to bilirubin by biliverdin reductase. Its role in the regulation of cellular homeostasis is widely documented. Studying regulation of HO-1 expression is important not only to understand the life of healthy cells but also the unbalances in cell metabolism that lead to disease.
Recent Advances:
The regulation of its enzymatic activity depends heavily upon changes in expression studied mainly at the transcriptional level. Current knowledge regarding HO-1 gene expression focuses primarily on transcription factors such as Nrf2 (nuclear factor erythroid 2-related factor 2), AP-1 (activator protein-1), and hypoxia-inducible factor, which collect signal transduction pathway information at the HO-1 gene promoter. Understanding of gene expression regulation is not limited to transcription factor activity but also involves an extended range of post- or cotranscriptional regulated events.
Critical Issues:
In addition to the regulation of gene promoter activity, alternative splicing, alternative polyadenylation, and regulation of messenger RNA stability play critical roles in changes in HO-1 gene expression levels, involving specific factors, proteins, and microRNAs. All potential targets for diagnosis or treatment of diseases are related to HO-1 dysregulation.
Future Directions:
Unbalances in the tightly regulated gene expression mechanisms lead to cell transformation and cancer development. Knowledge of these events and signal transduction cascades triggered by oncogenes in which HO-1 plays a critical role is of upmost importance for research in this field.
Get full access to this article
View all access options for this article.
References
1.
AbrahamNG and KappasA. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev, 60: 79–127, 2008.
2.
AlamJ and CookJL. How many transcription factors does it take to turn on the heme oxygenase-1 gene?. Am J Respir Cell Mol Biol, 36: 166–174, 2007.
3.
AlamJ, KilleenE, GongP, NaquinR, HuB, StewartD, IngelfingerJR, and NathKA. Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2. Am J Physiol Renal Physiol, 284: 743–752, 2003.
4.
AlamJ, StewartD, TouchardC, BoinapallyS, ChoiAM, and CookJL. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem, 274: 26071–26078, 1999.
5.
AlamJ, WicksC, StewartD, GongP, TouchardC, OtterbeinS, ChoiAM, BurowME, and TouJ. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem, 275: 27694–27702, 2000.
6.
BaisC, SantomassoB, CosoO, ArvanitakisL, RaakaEG, GutkindJS, AschAS, CesarmanE, GershengornMC, and MesriEA. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature, 391: 86–89, 1998.
7.
BalogunE, HoqueM, GongP, KilleenE, GreenCJ, ForestiR, AlamJ, and MotterliniR. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J, 371: 887–895, 2003.
8.
BancosS, BagloleCJ, RahmanI, and PhippsRP. Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Delta (12,14)-prostaglandin J(2) requires Nrf2. Cell Immunol, 262: 18–27. 2010.
9.
BianC, ZhongM, NisarMF, WuY, OuyangM, BartschJW, and ZhongJL. A novel heme oxygenase-1 splice variant, 14kDa HO-1, promotes cell proliferation and increases relative telomere length. Biochem Biophys Res Commun, 500: 429–434, 2018.
10.
BuckleyBJ, LiS, and WhortonAR. Keap1 modification and nuclear accumulation in response to S-nitrosocysteine. Free Radic Biol Med, 44: 692–698, 2008.
11.
ChenG, HitomiM, HanJ, and StaceyDW. The p38 pathway provides negative feedback for Ras proliferative signaling. J Biol Chem, 275: 38973–38980, 2000.
12.
ChengX, KuCH, and SiowRC. Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis. Free Radic Biol Med, 64: 4–11, 2013.
13.
DavisRJ.Signal transduction by the JNK group of MAP kinases. Cell, 103: 239–252, 2000.
14.
DegeseMS, TanosT, NaipauerJ, GingerichT, ChiappeD, EcheverriaP, LaMarreJ, GutkindJS, and CosoOA. An interplay between the p38 MAPK pathway and AUBPs regulates c-fos mRNA stability during mitogenic stimulation. Biochem J, 467: 77–90, 2015.
15.
DrummondGS, BaumJ, GreenbergM, LewisD, and AbrahamNG. HO-1 overexpression and underexpression: clinical implications. Arch Biochem Biophys, 673: 108073, 2019.
16.
FarombiEO and SurhYJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol, 39: 479–491, 2006.
17.
GandiniNA, AlonsoEN, FermentoME, MascaróM, AbbaMC, ColóGP, ArévaloJ, FerronatoMJ, GuevaraJA, NúñezM, PichelP, CurinoAC, and FacchinettiMM. Heme oxygenase-1 has an antitumor role in breast cancer. Antioxid Redox Signal, 30: 2030–2049, 2019.
18.
GueronG, GiudiceJ, ValaccoP, PaezA, ElgueroB, ToscaniM, JaworskiF, LeskowFC, CotignolaJ, MartiM, BinaghiM, NavoneN, and VazquezE. Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells. Oncotarget, 5: 4087–4102, 2014.
19.
HayashiS, OmataY, SakamotoH, HigashimotoY, HaraT, SagaraY, and NoguchiM. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene, 336: 241–250, 2004.
20.
HibiM, LinA, SmealT, MindenA, and KarinM. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev, 7: 2135–2148, 1993.
HwangHW, LeeJR, ChouKY, SuenCS, HwangMJ, ChenC, ShiehRC, and ChauLY. Oligomerization is crucial for the stability and function of heme oxygenase-1 in the endoplasmic reticulum. J Biol Chem, 284: 22672–22679, 2009.
23.
HwangYP, KimHG, HanEH, and JeongHG. Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner. Toxicol Appl Pharmacol, 231: 318–327, 2008.
24.
JazwaA, FlorczykU, JozkowiczA, and DulakJ. Gene therapy on demand: site specific regulation of gene therapy. Gene, 525: 229–238, 2013.
25.
JeongSO, OhGS, HaHY, Soon KooB, Sung KimH, KimYC, KimEC, LeeKM, ChungHT, and PaeHO. Dimethoxycurcumin, a synthetic curcumin analogue, induces heme oxygenase-1 expression through Nrf2 Activation in RAW264.7 macrophages. J Clin Biochem Nutr, 44: 79–84, 2009.
26.
JozkowiczA, WasH, and DulakJ. Heme oxygenase-1 in tumors: is it a false friend?. Antioxid Redox Signal, 9: 2099–2117, 2007.
27.
KangMI, KobayashiA, WakabayashiN, KimSG, and YamamotoM. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci U S A, 101: 2046–2051, 2004.
28.
KeumYS, YuS, ChangPP, YuanX, KimJH, XuC, HanJ, AgarwalA, and KongAN. Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells. Cancer Res, 66: 8804–8813, 2006.
29.
KietzmannT, SamoylenkoA, and ImmenschuhS. Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes. J Biol Chem, 278: 17927–17936, 2003.
30.
KimJW, LiMH, JangJH, NaHK, SongNY, LeeC, JohnsonJA, and SurhYJ. 15-Deoxy-Delta (12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. Biochem Pharmacol, 76: 1577–1589, 2008.
31.
KiveläAM, KansanenE, JyrkkänenHK, NurmiT, Ylä-HerttualaS, and LevonenAL. Enterolactone induces heme oxygenase-1 expression through nuclear factor-E2-related factor 2 activation in endothelial cells. J Nutr, 138: 1263–1268, 2008.
32.
KramerM, SponholzC, SlabaM, WissuwaB, ClausRA, MenzelU, HuseK, PlatzerM, and BauerM. Alternative 5′ untranslated regions are involved in expression regulation of human heme oxygenase-1. PLoS One, 8: e77224, 2013.
33.
KrönkeG, BochkovVN, HuberJ, GruberF, BlümlS, FürnkranzA, KadlA, BinderBR, and LeitingerN. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem, 278: 51006–51014, 2003.
34.
KuwanoY, RabinovicA, SrikantanS, GorospeM, and DempleB. Analysis of nitric oxide-stabilized mRNAs in human fibroblasts reveals HuR-dependent heme oxygenase 1 upregulation. Mol Cell Biol, 29: 2622–2635, 2009.
35.
LeeHH, ParkSA, AlmazariI, KimEH, NaHK, and SurhYJ. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling. Arch Biochem Biophys, 501: 142–150, 2010.
36.
LeePJ, JiangBH, ChinBY, IyerNV, AlamJ, SemenzaGL, and ChoiAM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem, 272: 5375–5381, 1997.
37.
LinQ, WeisS, YangG, WengYH, HelstonR, RishK, SmithA, BordnerJ, PolteT, GaunitzF, and DenneryPA. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem, 282: 20621–20633, 2007.
38.
LiuXM, PeytonKJ, EnsenatD, WangH, HanninkM, AlamJ, and DuranteW. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res, 75: 381–389, 2007.
39.
MarinissenMJ, TanosT, BolósM, de SagarraMR, CosoOA, and CuadradoA. Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor. J Biol Chem, 281: 11332–11346, 2006.
40.
MartinD, Rojo AIM, DiazR, GallardoG, AlamJ, De GalarretaCM, and CuadradoA. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem, 279: 8919–8929, 2004.
41.
MartínMJ, TanosT, GarcíaAB, MartinD, GutkindJS, CosoOA, and MarinissenMJ. The Galpha12/13 family of heterotrimeric G proteins and the small GTPase RhoA link the Kaposi sarcoma-associated herpes virus G protein-coupled receptor to heme oxygenase-1 expression and tumorigenesis. J Biol Chem, 282: 34510–34524, 2007.
42.
MayrC.Evolution and biological roles of alternative 3'UTRs. Trends Cell Biol, 26: 227–237, 2016.
43.
MayrC and BartelDP. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell, 138: 673–684, 2009.
44.
MonjeP, MarinissenMJ, and GutkindJS. Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol Cell Biol, 23: 7030–7043, 2003.
45.
MontanerS, SodhiA, RamsdellAK, MartinD, HuJ, SawaiET, and GutkindJS. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res, 66: 168–174, 2006.
46.
MontanerS, SodhiA, ServitjaJM, RamsdellAK, BaracA, SawaiET, and GutkindJS. The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood, 104: 2903–2911, 2004.
47.
MoosaviF, HosseiniR, SasoL, and FiruziO. Modulation of neurotrophic signaling pathways by polyphenols. Drug Des Devel Ther, 210: 23–42, 2015.
48.
NaHK and SurhYJ. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1. Free Radic Biol Med, 67: 353–365, 2014.
49.
NaiduS, VijayanV, SantosoS, KietzmannT, and ImmenschuhS. Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via Nrf2. J Immunol, 182: 7048–7057, 2009.
50.
NaipauerJ, GattelliA, DegeseMS, SlomianskyV, WertheimerE, LaMarreJ, CastillaL, AbbaM, KordonEC, and CosoOA. The use of alternative polyadenylation sites renders integrin β1 (Itgb1) mRNA isoforms with differential stability during mammary gland development. Biochem J, 454: 345–357, 2013.
51.
OgborneRM, RushworthSA, and O'ConnellMA. Epigallocatechin activates haem oxygenase-1 expression via protein kinase Cdelta and Nrf2. Biochem Biophys Res Commun, 373: 584–588, 2008.
52.
PaineA, Eiz-VesperB, BlasczykR, and ImmenschuhS. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol, 80: 1895–1903, 2010.
53.
PearsonG, RobinsonF, Beers GibsonT, XuBE, KarandikarM, BermanK, and CobbMH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev, 22: 153–183, 2001.
54.
PetersonSJ, RubinsteinR, FaroquiM, RazaA, BoumazaI, ZhangY, StecD, and AbrahamNG. Positive effects of heme oxygenase upregulation on adiposity and vascular dysfunction: gene targeting vs. pharmacologic therapy. Int J Mol Sci, 20: pii: E2514, 2019.
55.
PodkalickaP, MuchaO, JózkowiczA, DulakJ, and ŁobodaA. Heme oxygenase inhibition in cancers: possible tools and targets. Contemp Oncol (Pozn), 22(1A): 23–32, 2018.
56.
RaffaeleM, PittalàV, ZingalesV, BarbagalloI, SalernoL, Li VoltiG, RomeoG, CarotaG, SorrentiV, and VanellaL. Heme oxygenase-1 inhibition sensitizes human prostate cancer cells towards glucose deprivation and metformin-mediated cell death. Int J Mol Sci, 20: pii: E2593, 2019.
57.
ReismanSA, BuckleyDB, TanakaY, and KlaassenCD. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes. Toxicol Appl Pharmacol, 236: 109–114, 2009.
58.
SalinasM, DiazR, AbrahamNG, Ruiz de GalarretaCM, and CuadradoA. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem, 278: 13898–13904, 2003.
59.
SapochnikD, RaimondiA, MedinaV, NaipauerJ, MesriE, and CosoO.A major Role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes. BioRxiv, 2019. DOI: http://dx.doi.org/10.1101/678342.
60.
SardanaMK and KappasA. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci U S A, 84: 2464–2468, 2987.
61.
SengS, AvrahamHK, BirraneG, JiangS, and AvrahamS. Nuclear matrix protein (NRP/B) modulates the nuclear factor (Erythroid-derived 2)-related 2 (NRF2)-dependent oxidative stress response. J Biol Chem, 285: 26190–26198, 2010.
62.
ShanY, LambrechtRW, DonohueSE, and BonkovskyHL. Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J, 20: 2651–2653, 2006.
63.
SheltonP and JaiswalAK. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?. FASEB J, 27: 414–423, 2013.
64.
ShiJ, YuJ, ZhangY, WuL, DongS, WuL, WuL, DuS, ZhangY, and MaD. PI3K/Akt pathway-mediated HO-1 induction regulates mitochondrial quality control and attenuates endotoxin-induced acute lung injury. Lab Invest, 99: 1795–1809, 2019.
65.
ShibaharaS, SatoM, MullerRM, and YoshidaT. Structural organization of the human heme oxygenase gene and the function of its promoter. Eur J Biochem, 179: 557–563, 1989.
66.
ShinJH, KimKM, JeongJU, ShinJM, KangJH, BangK, and KimJH. Nrf2-Heme oxygenase-1 attenuates high-glucose-induced epithelial-to-mesenchymal transition of renal tubule cells by inhibiting ROS-mediated PI3K/Akt/GSK-3β signaling. J Diabetes Res, 2019: 2510105, 2019.
67.
SinerJM, JiangG, CohenZI, ShanP, ZhangX, LeeCG, EliasJA, and LeePJ. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. FASEB J, 21: 1422–1432, 2007.
68.
SinghSP, McClungJA, ThompsonE, GlickY, GreenbergM, Acosta-BaezG, EdrisB, ShapiroJI, and AbrahamNG. Cardioprotective heme oxygenase-1-PGC1α signaling in epicardial fat attenuates cardiovascular risk in humans as in obese mice. Obesity (Silver Spring), 27: 1634–1643, 2019.
69.
SirianniMC, VincenziL, FiorelliV, TopinoS, ScalaE, UcciniS, AngeloniA, FaggioniA, CerimeleD, CottoniF, AiutiF, and EnsoliB. Gamma-interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood, 91: 968–976, 1998.
70.
SoHS, KimHJ, LeeJH, LeeJH, ParkSY, ParkC, KimYH, KimJK, LeeKM, KimKS, ChungSY, JangWC, MoonSK, ChungHT, and ParkRK. Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin. Cell Death Differ, 13: 1763–1775, 2006.
71.
SodhiA, MontanerS, MiyazakiH, and GutkindJS. MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. Biochem Biophys Res Commun, 287: 292–300, 2001.
72.
SodhiA, MontanerS, PatelV, ZoharM, BaisC, MesriEA, and GutkindJS. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res, 60: 4873–4880, 2000.
73.
SongJ, ZhangX, LiaoZ, LiangH, ChuL, DongW, ZhangX, GeQ, LiuQ, FanP, ZhangZ, and ZhangB. 14-3-3ζ inhibits heme oxygenase-1 (HO-1) degradation and promotes hepatocellular carcinoma proliferation: involvement of STAT3 signaling. J Exp Clin Cancer Res, 38: 3, 2019.
74.
StachurskaA, CieslaM, KozakowskaM, WolfframS, Boesch-SaadatmandiC, RimbachG, JozkowiczA, DulakJ, and LobodaA. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol Nutr Food Res, 57: 504–515, 2013.
75.
SunXQ, WuC, QiuYB, WuYX, ChenJL, HuangJF, ChenD, and PangQF. Heme oxygenase-1 attenuates seawater drowning-induced acute lung injury through a reduction in inflammation and oxidative stress. Int Immunopharmacol, 74: 105634, 2019.
76.
SurhYJ, KunduJK, LiMH, NaHK, and ChaYN. Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch Pharm Res, 32: 1163–1176, 2009.
77.
TanosT, MarinissenMJ, LeskowFC, HochbaumD, MartinettoH, GutkindJS, and CosoOA. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem, 280: 18842–18852, 2005.
78.
WarabiE, TakabeW, MinamiT, InoueK, ItohK, YamamotoM, IshiiT, KodamaT, and NoguchiN. Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radic Biol Med, 42: 260–269, 2007.
79.
XuC, YuanX, PanZ, ShenG, KimJH, YuS, KhorTO, LiW, MaJ, and KongAN. Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther, 5: 1918–1926, 2006.
